Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03773302 |
| Consolidated Lead Sponsor | QED Therapeutics, a BridgeBio company |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 48 participants (ACTUAL) |
| Registered Start Date | 2019-12-27 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert, AZ | Open Hospital Dossier -> |
| University of Arizona | Tucson, AZ | Open Hospital Dossier -> |
| University of Arkansas for Medical Sciences | Little Rock, AR | Open Hospital Dossier -> |
| USC Norris Comprehensive Cancer Center and Keck Medicine | Los Angeles, CA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.